Harmony Biosciences Holdings, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Harmony Biosciences Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was 23.2 %, a 30.4% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2023 was 27.5 %, a 54.3% decline from 2022.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2022 was 60.1 %, a 149% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Return On Equity for 2021 was 24.2 %, a 24.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 27.5 -32.6 -54.3% Jan 1, 2023 Dec 31, 2023
2022 60.1 +36 +149% Jan 1, 2022 Dec 31, 2022
2021 24.2 +4.81 +24.9% Jan 1, 2021 Dec 31, 2021
2020 19.3 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.